At the very beginning of all these processes is a cell.
Imagine you could simply skip all recombinant DNA work and proceed right to the product, to the screening of your library or the verification of your experiment.
Occam Plug&Play enables this. Our high-producing cell lines – already now available – is able to produce at high titers and tolerate toxic gene expression stress and will soon be able to integrate any gene of interest you provide in a single step. This significantly reduces the hands-on time and the cost of your R&D
Gene expression toxicity is an important biological phenomenon and a major bottleneck in biotechnology. Escherichia coli BL21(DE3) is the most popular choice for recombinant protein production, and various derivatives have been evolved or engineered to facilitate improved yield and tolerance to toxic genes...
© Bax Lindhardt
Sophia is a young scientist that is driven by the potential for life science to make our world better and to advance towards a greener, healthier and more sustainable future. She has a PhD in Microbial Engineering and Synthetic Biology from the Technical University of Denmark. During her research career, Sophia has been a visiting scientist at UC Berkeley, University of Oxford and University of New South Wales, and recently founded a sustainability initiative at DTU. In her spare time, Sophia likes to hike, dive and paint.
%201.svg)
%201.svg)
Morten is a PI and research group leader with 20 years of experience in synthetic biology, protein production and genetic engineering. He has a MSc in biochemistry and a PhD degree in molecular biology from the University of Copenhagen, has been a visiting scientist at Harvard Medicalschool and a postdoc at Stockholm University.Morten is also a co-owner oftwo biotech startups CloneOpt AB and Mycropt ApS. In his spare time, Morten misses no chance to support the Danish national football team.
